Systemic Lupus Erythematosus and Cytokine Storm

Area of Science:

• Rheumatology
• Immunology
• Internal Medicine

Background:

• Systemic lupus erythematosus (SLE) is a complex autoimmune disease with diverse clinical and laboratory manifestations.
• Macrophage activation syndrome (MAS) is a severe, life-threatening complication of SLE.
• Diagnosing MAS in SLE patients is challenging due to overlapping symptoms with disease flares and infections.

Purpose of the Study:

• To provide a comprehensive overview of MAS in the context of SLE.
• To discuss the pathogenesis, clinical presentation, and treatment of SLE-associated MAS.
• To highlight future directions in managing this critical condition.

Main Methods:

• Literature review and synthesis of existing research on MAS and SLE.
• Analysis of clinical presentations in pediatric versus adult SLE patients with MAS.
• Discussion of current and emerging treatment strategies for SLE-associated MAS.

Main Results:

• MAS presents diagnostic challenges in SLE due to similar symptoms like fever, lymphadenopathy, splenomegaly, and cytopenias.
• Untreated MAS is invariably lethal, and even with treatment, mortality rates remain high.
• Differences in MAS presentation may exist between pediatric and adult SLE patients.

Conclusions:

• MAS is a critical complication of SLE requiring prompt recognition and management.
• Understanding the pathogenesis and distinct presentations is key to improving patient outcomes.
• Further research into novel therapeutic approaches is essential for reducing mortality in SLE-associated MAS.